Literature DB >> 3558091

Pseudohyperkalemia in Akitas.

M Degen.   

Abstract

Hyperkalemia was observed in a clinically normal Akita with normal ACTH stimulation test results, endogenous ACTH concentration, and SUN concentration. A diagnosis of pseudohyperkalemia caused by red cell hemolysis was made by comparing plasma potassium content from hemolyzed and non-hemolyzed specimens. Red cell potassium content was measured in 8 Akitas and 6 non-Akita control dogs. Six of 8 Akitas had high erythrocyte potassium content relative to their plasma and to that of the control dogs. Five of eight Akitas had microcytosis. Plasma from affected dogs had high potassium content after being refrigerated in contact with red cells for 4 hours or more. The increase in plasma potassium content was progressive with prolonged contact with the red cells and was accompanied by a decrease in plasma sodium content.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3558091

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  4 in total

1.  Interference of haemolysis and hyperproteinemia on sodium, potassium, and chloride measurements in canine serum samples.

Authors:  D Bernardini; G Gerardi; B Contiero; M Caldin
Journal:  Vet Res Commun       Date:  2009-09       Impact factor: 2.459

2.  An unusual form of canine babesiosis.

Authors:  Isabel Van de Maele; Karine Savary-Bataille; Ingrid Gielen; Sylvie Daminet
Journal:  Can Vet J       Date:  2008-03       Impact factor: 1.008

3.  Breed-specific hematological phenotypes in the dog: a natural resource for the genetic dissection of hematological parameters in a mammalian species.

Authors:  Jennifer Lawrence; Yu-Mei Ruby Chang; Balazs Szladovits; Lucy J Davison; Oliver A Garden
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

4.  Evaluation of Iron Deficiency Using Reticulocyte Indices in Dogs Enrolled in a Blood Donor Program.

Authors:  D S Foy; K R Friedrichs; J F Bach
Journal:  J Vet Intern Med       Date:  2015 Sep-Oct       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.